Live

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

The True Post icon
By The True Post
No Comments
Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.

Source: CNBC

Share This Article
The True Post icon
ByThe True Post
The newsroom of The True Post.
Leave a Comment

Related Stories

Uncover the stories that related to the post!
Americans want answers on Social Security this midterm season
Live

Americans want answers on Social Security this midterm season

Parents are interfering with teens’ first jobs. Here’s why employers say it can backfire
Live

Parents are interfering with teens’ first jobs. Here’s why employers say it can backfire

1 in 3 Americans with health insurance have medical debt, survey finds
Live

1 in 3 Americans with health insurance have medical debt, survey finds

‘We Don’t Need Canada’: Trump Escalates Trade War With Threat of 50% Auto Tariffs
Live

‘We Don’t Need Canada’: Trump Escalates Trade War With Threat of 50% Auto Tariffs

Anthropic and OpenAI need truly independent safety evaluators, experts say in public letter
Live

Anthropic and OpenAI need truly independent safety evaluators, experts say in public letter

How the NYPD is preparing for the U.N. General Assembly
Live

How the NYPD is preparing for the U.N. General Assembly

Appeals court weighs Missouri congressional map despite Supreme Court block
Live

Appeals court weighs Missouri congressional map despite Supreme Court block

Sacramento Sikh truck driver survives being stabbed 17 times at Wyoming rest stop
Live

Sacramento Sikh truck driver survives being stabbed 17 times at Wyoming rest stop

Show More